OZEM ETF (Roundhill GLP-1 & Weight Loss ETF) is managed by Roundhill Investments with $63.7M in net assets. OZEM expense ratio is 0.59%, holding 28 positions across sectors including Health Care, Unknown, Financials. Inception date: 2024-05-21.

OZEM performance shows a YTD return of -5.22%. The 1-year return is 30.30%. OZEM dividend yield stands at 1.27%, paid annually.

OZEM top holdings include Eli Lilly & Co (16.4%), Novo-Nordisk A/S-Spons Adr (15.1%), Pfizer, Inc. (7.2%), Innovent Biologics Inc (5.5%), Viking Therapeutics Inc Com (5.1%). View all OZEM holdings, sector breakdown, or dividend history.

OZEM can be compared against other funds using the overlap calculator or side-by-side comparison tool. OZEM alternatives are available via the screener, along with tax-loss harvesting opportunities.